Surmodics, Inc. (NASDAQ:SRDX) Q2 2024 Earnings Call Transcript
Surmodics, Inc. beats earnings expectations. Reported EPS is $0.01742, expectations were $-0.36. Surmodics, Inc.
Posts Tagged ‘NASDAQ:SRDX’
Surmodics, Inc. (NASDAQ:SRDX) Q1 2024 Earnings Call Transcript
Operator: Welcome everyone to the Surmodics First Quarter of Fiscal Year 2024 Earnings Call. Please note that this call is being webcast.
Surmodics, Inc. (NASDAQ:SRDX) Q4 2023 Earnings Call Transcript
Operator: Welcome everyone to Surmodics Fourth Quarter and Fiscal Year 2023 Earnings Call. Please note that this call is being webcast.
Surmodics, Inc. (NASDAQ:SRDX) Q3 2023 Earnings Call Transcript
Operator: Welcome everyone to Surmodics Third Quarter of Fiscal Year 2023 Earnings Call. Please note that this call is being webcast.
Surmodics, Inc. (NASDAQ:SRDX) Q2 2023 Earnings Call Transcript
Operator: Welcome everyone to Surmodics’ Second Quarter and Fiscal Year 2023 Earnings Call. Please note that this call is being webcast.
Surmodics, Inc. (NASDAQ:SRDX) Q1 2023 Earnings Call Transcript
Operator: Welcome everyone to Surmodics' First Quarter of Fiscal Year 2023 Earnings Call. Please note that this call is being webcast.
Is SRDX A Good Stock To Buy Now?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Do Hedge Funds Love SurModics, Inc. (SRDX)?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file ...
Should You Avoid SurModics, Inc. (SRDX)?
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
Here’s What Hedge Funds Think About SurModics, Inc. (SRDX)
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Hedge Funds Have Never Been More Bullish On SurModics, Inc. (SRDX)
Hedge funds are known to underperform the bull markets but that's not because they are terrible at stock picking.
Hedge Funds Have Never Been This Bullish On SurModics, Inc. (SRDX)
Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to...
Is SurModics, Inc. (SRDX) Worthy of Your Portfolio?
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks...
Why Synta Pharmaceuticals Corp. (SNTA) May Be Worth Selling
If you were to ask many of your peers, hedge funds are assumed to be overrated, outdated financial vehicles of a forgotten age.
This Metric Says You Are Smart to Buy Trinity Biotech plc (ADR) (TRIB)
If you'd ask most market participants, hedge funds are seen as slow, outdated investment vehicles of years past.
Do Hedge Funds and Insiders Love SurModics, Inc. (SRDX)?
SurModics, Inc. (NASDAQ:SRDX) was in 8 hedge funds' portfolio at the end of March.
How Are Hedge Funds Trading AMAG Pharmaceuticals, Inc. (AMAG)?
Is AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) the right pick for your portfolio? Prominent investors are taking a pessimistic view.
SurModics, Inc. (SRDX): The Details
Here at The Motley Fool, I've long cautioned investors to keep a close eye on inventory levels.
Hedge Funds Are Dumping Trinity Biotech plc (ADR) (TRIB)
Is Trinity Biotech plc (ADR) (NASDAQ:TRIB) a sound investment now? Hedge funds are reducing their bets on the stock.
SurModics, Inc. (SRDX): Insiders Are Dumping, Should You?
Is SurModics, Inc. (NASDAQ:SRDX) worth your attention right now? Hedge funds are in a pessimistic mood.
This Metric Says You Are Smart to Buy Synta Pharmaceuticals Corp. (SNTA)
In the 21st century investor’s toolkit, there are plenty of metrics shareholders can use to monitor their holdings.
